Literature DB >> 9600908

A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.

S Hornemann1, R Glockshuber.   

Abstract

The infectious agent of transmissible spongiform encephalopathies is believed to consist of an oligomeric isoform, PrPSc, of the monomeric cellular prion protein, PrPC. The conversion of PrPC to PrPSc is characterized by a decrease in alpha-helical structure, an increase in beta-sheet content, and the formation of PrPSc amyloid. Whereas the N-terminal part of PrPC comprising residues 23-120 is flexibly disordered, its C-terminal part, PrP(121-231), forms a globular domain with three alpha-helices and a small beta-sheet. Because the segment of residues 90-231 is protease-resistant in PrPSc, it is most likely structured in the PrPSc form. The conformational change of the segment containing residues 90-120 thus constitutes the minimal structural difference between PrPC and a PrPSc monomer. To test whether PrP(121-231) is also capable to undergo conformational transitions, we analyzed its urea-dependent unfolding transitions at neutral and acidic pH. We identified an equilibrium unfolding intermediate of PrP(121-231) that is exclusively populated at acidic pH and shows spectral characteristics of a beta-sheet protein. The intermediate is in rapid equilibrium with native PrP(121-231), significantly populated in the absence of urea at pH 4.0, and may have important implications for the presumed formation of PrPSc during endocytosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600908      PMCID: PMC27576          DOI: 10.1073/pnas.95.11.6010

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Global analysis of the acid-induced and urea-induced unfolding of staphylococcal nuclease and two of its variants.

Authors:  R M Ionescu; M R Eftink
Journal:  Biochemistry       Date:  1997-02-04       Impact factor: 3.162

2.  Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.

Authors:  S Hornemann; R Glockshuber
Journal:  J Mol Biol       Date:  1996-09-06       Impact factor: 5.469

Review 3.  Prionics or the kinetic basis of prion diseases.

Authors:  M Eigen
Journal:  Biophys Chem       Date:  1996-12-10       Impact factor: 2.352

4.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.

Authors:  D R Booth; M Sunde; V Bellotti; C V Robinson; W L Hutchinson; P E Fraser; P N Hawkins; C M Dobson; S E Radford; C C Blake; M B Pepys
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.

Authors:  M Vey; S Pilkuhn; H Wille; R Nixon; S J DeArmond; E J Smart; R G Anderson; A Taraboulos; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Measurement of endosome pH following folate receptor-mediated endocytosis.

Authors:  R J Lee; S Wang; P S Low
Journal:  Biochim Biophys Acta       Date:  1996-07-24

7.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

8.  Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.

Authors:  C Blake; L Serpell
Journal:  Structure       Date:  1996-08-15       Impact factor: 5.006

9.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

10.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

View more
  61 in total

Review 1.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

2.  Sequence determinants of amyloid fibril formation.

Authors:  Manuela López de la Paz; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  The peculiar nature of unfolding of the human prion protein.

Authors:  Ilia V Baskakov; Giuseppe Legname; Zygmunt Gryczynski; Stanley B Prusiner
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

4.  The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment.

Authors:  Carlos J Bosques; Barbara Imperiali
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

5.  Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.

Authors:  Masakazu Sekijima; Chie Motono; Satoshi Yamasaki; Kiyotoshi Kaneko; Yutaka Akiyama
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 6.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

7.  Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.

Authors:  Abdessamad Tahiri-Alaoui; William James
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

8.  Misfolding pathways of the prion protein probed by molecular dynamics simulations.

Authors:  Alessandro Barducci; Riccardo Chelli; Piero Procacci; Vincenzo Schettino
Journal:  Biophys J       Date:  2004-11-19       Impact factor: 4.033

9.  Influence of the N-terminal domain on the aggregation properties of the prion protein.

Authors:  Kristen N Frankenfield; Evan T Powers; Jeffery W Kelly
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

10.  Enhanced stability of human prion proteins with two disulfide bridges.

Authors:  Tuomas P J Knowles; Ralph Zahn
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.